Zydus Cadila gets USFDA nod to market Fingolimod capsules, Verapamil Hydrochloride Injection

  • by
Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Fingolimod capsules, (Gilenya) in the strengths of 0.5 mg, Zydus Cadila, part of Cadila Healthcare group, said in a regulatory filing.